[Federal Register Volume 71, Number 99 (Tuesday, May 23, 2006)]
[Notices]
[Pages 29653-29654]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-7857]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; Comment Request; ActiGraph Accelerometer 
Validation Study

    Summary: Under the provisions of Section 3507(a)(1)(D) of the 
Paperwork Reduction Act of 1995, the National Cancer Institute (NCI), 
the National Institutes of Health (NIH) has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below. This proposed information 
collection was previously published in the Federal Register on January 
23, 2006, page 3312 and allowed 60-days for public comment. One public 
comment was received. The purpose of this notice is to allow an 
additional 30 days for public comment. The National Institutes of 
Health may not conduct or sponsor, and the respondent is not required 
to respond to, an information collection that has been extended, 
revised, or implemented on or after October 1, 1995, unless it displays 
a currently valid OMB control number.
    Proposed Collection: Title: Actigraph Accelerometer Validation 
Study Type of Information Collection Request: New. Need and Use of 
Information Collection: The NCI is collaborating with other NIH 
Institutes on a proposed longitudinal study of Hispanic subpopulations 
in the United States referred to as the Hispanic Community Health 
Study. The Hispanic population is now the largest minority population 
in the U.S. with a projected three-fold growth by 2050. Hispanic 
subgroups are influenced by a number of chronic disease risk factors 
associated with immigration from different cultural settings and 
environments. These factors include diet, physical activity, community 
support, working conditions, and access to health care. Hispanic groups 
have higher rates of obesity and diabetes than non-Hispanic groups, but 
have lower coronary disease and cancer (all sites) mortality. There are 
also observed differences in health outcomes between Hispanic 
subgroups. For example, Puerto Ricans have a four-fold higher asthma 
prevalence than Mexican-Americans. Hispanic populations are 
understudied with respect to many diseases and risk factors. Their 
projected population growth underscores the need for accurate 
evaluation of their disease burden and risk. A vast amount of research 
suggests that the level of physical activity influences many of the 
chronic diseases and conditions of interest, including obesity, 
diabetes, cardiovascular disease, and cancer. To better understand the 
relationship between physical activity and chronic disease, and to make 
specific activity prescriptions, it is necessary to be able to 
accurately assess levels and types of activity. In particular, better 
methods are needed to improve the validity and reliability of physical 
activity assessment instruments to better assess the frequency, 
duration, and intensity of physical activity. For that reason, NCI 
plans to evaluate the use of a new type of accelerometer, a small 
device worn on a belt at the waist that measures and

[[Page 29654]]

records movement, capturing movement intensity and duration and 
associating it with clock-time. This new accelerometer will be used in 
the Hispanic Community Health Study and will allow examination of 
levels as well as patterns of activity. Physical activity was measured 
with accelerometers in the nationally representative 2003-2006 National 
Health and Nutrition Examination Survey (NHANES) (OMB: 0920-
0237, October 15, 2004, Vol 69, pp. 61253-61254). NHANES provides 
estimates for Mexican-American, but not other Hispanic subgroups. 
Between the time of the NHANES and the Hispanic Community Health Study, 
there has been a change in the technology of the accelerometer used in 
NHANES. To allow comparison of the physical activity data that will be 
collected from the four Hispanic subgroups in the Hispanic Community 
Study to the data collected with the previous technology used in 
NHANES, a cross-validation study is needed. The proposed study, the 
ActiGraph Accelerometer Validation Study, will serve this purpose. It 
is a cross-validation study comparing the two ActiGraph accelerometer 
models under different circumstances of walking or jogging in differing 
age groups and for both genders. Frequency of response: One-time study. 
Affected Public: Individuals. Type of Respondents: Healthy adults 
between the ages of 18-74 years. The annual reporting burden is as 
follows: Estimated Number of Respondents: 144; Estimated Number of 
Responses per Respondent: 1.14; Average Burden Hours Per Response: 
0.66; and Estimated Total Annual Burden Hours Requested: 62. The 
annualized cost to respondents is estimated at: $1116.

----------------------------------------------------------------------------------------------------------------
                                                                Average
     Data Collection Task          Number of      Frequency     time per   Annual hour  Hourly wage    Cost to
                                  participants   of response    response      burden        rate       respond
----------------------------------------------------------------------------------------------------------------
Screener......................              144            1         0.25           12       $18.00         $216
Height and weight.............              120            1         0.25           10        18.00          180
Accelerometer fitting.........              120            1          0.5           20        18.00          360
Walking track.................              120            1          0.5           20        18.00          360
                                                                     0.66           62  ...........         1116
----------------------------------------------------------------------------------------------------------------

    There are no Capital Costs to report. There are no Operating or 
Maintenance Costs to report.
    Request for Comments: Written comments and/or suggestions from the 
public and affected agencies are invited on one or more of the 
following points: (1) Whether the proposed collection of information is 
necessary for the proper performance of the function of the agency, 
including whether the information will have practical utility, (2) The 
accuracy of the agency's estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used, (3) Ways to enhance the quality, utility and 
clarity of the information to be collected; and (4) Ways to minimize 
the burden of the collection of information on those who are to 
respond, including the use of appropriate automated, electronic, 
mechanical, or other technological collection techniques or other forms 
of information technology.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, New Executive Office Building, Room 10235, Washington, DC 
20503, Attention: Desk Officer for NIH. To request more information on 
the proposed project or to obtain a copy of the data collection plans 
and instruments, contact Dr. Richard Troiano, CDR, U.S. Public Health 
Service, Risk Factor Monitoring and Methods Branch, Applied Research 
Program, Division of Cancer Control and Population Sciences, National 
Cancer Institute, EPN 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 
20892-7344, or call non-toll-free number 301-435-6822, or FAX your 
request to (301) 435-3710, or E-mail your request, including your 
address, to: [email protected].
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

    Dated: May 16, 2006.
Rachelle Ragland-Greene,
NCI Project Clearance Liaison, National Institutes of Health.
 [FR Doc. E6-7857 Filed 5-22-06; 8:45 am]
BILLING CODE 4140-01-P